Amarin | AMRN - Capitalisation Boursière





Capitalisation Boursière Changement Date
AbbVie USD 435.86B 8.73B 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
AstraZeneca USD 178.16B 111.83B 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
DBV Technologies USD 1.23B 327M 2026-03
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06